Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy

AIDS

Volumn 14, Issue 9, 2000, Pages 1163-1170

  Deayton, Jane R ^a   Wilson, Pauline ^a   Sabin, Caroline A ^a   Davey, Clare C ^a   Johnson, Margaret A ^a   Emery, Vincent C ^a   Griffiths, Paul D ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cystoid macular oedema; Cytomegalovirus; Highly active antiretroviral therapy; Natural history; Retinitis; Vitritis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ADULT; ARTICLE; CELL COUNT; CYTOMEGALIC INCLUSION BODY DISEASE; DEATH; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE ATROPHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINITIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; UVEITIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; CYTOMEGALOVIRUS RETINITIS; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFLAMMATION; LONDON; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 0033930811     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200006160-00013     Document Type: Article

References (29)

1. 1. Centres for Disease Control and Prevention. Update: trends in AIDS incidence. MMWR 1997, 46:861-867.
2. 2. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853-860.
3. 3. Mocroft A, Vella S, Benfield T, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998, 352:1725-1730.
4. 4. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997, 349:1443.
5. 5. Gilquin J, Piketty C, Thomas V, et al. Acute cytomegalovirus infection in AIDS patients with CD4 counts above 100 x 106 cells/I following combination antiretroviral therapy including protease inhibitors. AIDS 1997, 11:1659-1660.
6. 6. Mallolas J, Arrizabalga J, Loncá M, et al. Cytomegalovirus disease in HIV-infected patients treated with protease inhibitors. AIDS 1997, 11:1785-1787.
7. 7. Whitcup SM, Fortin E, Nussenblatt RB, et al. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. JAMA 1997, 277:1519-1520.
8. 8. Reed JB, Schawb IR, Gordon J, et al. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol 1997, 124:199-205.
9. 9. Bowen EF, Sabin C, Wilson P, et al. Cytomegalovirus viraemia detected by polymerase chain reaction identifies a group of patients at high risk of CMV disease. AIDS 1997, 11:889-893.
10. 10. Walsh JC, Jones CD, Barnes EA, et al. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors. AIDS 1998, 12:613-618.
11. 11. Tural C, Romeu J, Sirera G, et al. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis 1997, 177:1080-1083.
12. 12. Macdonald JC, Torriani FJ, Morse LS, et al. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis 1998, 177:1182-1187.
13. 13. Vrabec TR, Baldassano VF, Whitcup SM. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4 counts. Ophthalmology 1998, 105:1259-1264.
14. 14. Silverstein BE, Smith JH, Hasenyager Smith J, et al. Cystoid macular edema associated with patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1998, 125: 411-415.
15. 15. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
16. 16. Li TS, Tubiana R, Katlama C, et al. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998, 351:1682-1686.
17. 17. Komanduri KV, Viswanathan MN, Wieder ED, et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998, 4:953-956.
18. 18. Elliot B, Aromin I, Gold R, et al. 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Lancet 1997, 349:850.
19. 19. Murphy M, Armstrong D, Sepkowitz KA, et al. Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-1 protease inhibitor. AIDS 1997, 11:261-262.
20. 20. Conant MA, Opp KM, Poretz D, Mills RG. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonavir. AIDS 1997, 11:1300-1301.
21. 21. Blum L, Pellet C, Abgalika F, et al. Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy. AIDS 1997, 11:1653-1655.
22. 22. Goguel J, Katlama C, Sarfati C, et al. Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy. AIDS 1997, 11:1658.
23. 23. Carr A, Marriott D, Field A, et al. Treatment of HIV-1 associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet 1998, 351:256-261.
24. 24. Race EM, Adelson-Mitty J, Kriegel GR, et al. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998, 351: 252-255.
25. 25. Torriani F, Durand FD, Karavellas M, et al. Evidence that HAART induced immune recovery vitritis in CMV retinitis patients is immune mediated. XIIth World AIDS Conference. Geneva, 1998. [Abstract 15/22240].
26. 26. Karavellas MP, Lowder CY, Macdonald C, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 1998, 116:169-175.
27. 27. Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998, 125:292-300.
28. 28. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998, 12:F51-F58.
29. 29. Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet 1999, 353:863-868.